Most. Israt Jahan Oni

Most. Israt Jahan Oni

Auto-generated profile, based on publicly available information

Most. Israt Jahan Oni

Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj 8100, Bangladesh

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Food Biochemistry
Verified
Journal Article
Open access
MOMost. Israt Jahan Oni
Most. Israt Jahan Oni
Md. Shimul BhuiaMd. Shimul Bhuia
Md. Shimul Bhuia
Raihan ChowdhuryRaihan Chowdhury
Raihan Chowdhury
SSSalehin Sheikh
Salehin Sheikh
MMMd. Hanif Munshi
Md. Hanif Munshi
MIMd. Torequl Islam
Md. Torequl Islam
Natural compounds and their derivatives have been identified as valuable sources of therapeutic ingredients for cancer treatment. The naturally occurring phytochemical palmatine (isoquinoline alkaloid) is extracted from plant parts (rhizomes, roots, stems, stem barks, and others) and has protective effects including antioxidant, anti‐inflammatory, and anticancer. This study aims to summarize the anticancer potential of palmatine and its derivatives in the treatment of numerous types of cancer with molecular mechanisms. We also include the pharmacokinetic features, botanical origin, and toxicological characteristics of palmatine and its derivatives. For this, data have been collected from plausible different electronic databases, including PubMed, Google Scholar, PubChem, Science Direct, Web of Science, Scopus, Springer Link, and Wiley Online. The findings demonstrate that palmatine and its derivatives have a protective anticancer effect against a variety of cancers, including breast, colorectal, gastric, ovarian, prostate, pancreatic, skin, hepatocellular cancer, and mammary gland tumors. They provoke their anticancer properties against various cancer cell lines via modifying molecular mechanisms like induction of oxidative stress, cytotoxicity, apoptosis, inhibition of cell invasion and migration, arresting the cell cycle at the S phase, antiproliferative, and antiangiogenic effects. It is suggested that palmatine and its derivatives may be a good option in the development of novel drugs for cancer therapy in the future.

28 March 2025 in Journal of Phytochemical Insights
Verified
Journal Article
Open access
PDF file
JSJakia Sultana
Jakia Sultana
MOMost. Israt Jahan Oni
Most. Israt Jahan Oni
SHShadin
Shadin
Apigenin (APG), a flavonoid found in various fruits, vegetables, and herbs, has gained attention for its anticancer properties. This review summarizes the various botanical origins, physiochemical & biopharmaceutical properties of APG and its anticancer activity across different cancer types by investigating its effects on various cancer cell lines, underlying mechanisms, and effective doses. Studies indicate that APG exerts its anticancer effects by inhibiting cell proliferation, inducing apoptosis, and promoting autophagy. Additionally, APG has been shown to trigger necroptosis in cancer cells, contributing to its anticancer potential. The data highlights the ability of APG to suppress cancer cell growth, migration, and invasion, with varying effective doses depending on the cancer type. This review exhibits the potential of APG as a promising anticancer agent, revealing its therapeutic applications. However, further research, particularly clinical trials, is needed to optimize dosing and assess its full therapeutic potential in cancer treatment

8 March 2025 in Journal of Medicinal Chemistry and Therapeutics
Verified
Journal Article
Open access
PDF file
MKMst Muslima Khatun
Mst Muslima Khatun
MOMost. Israt Jahan Oni
Most. Israt Jahan Oni
MSM Shadin
M Shadin
BBB S M Bodiuzzaman
B S M Bodiuzzaman
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and neuronal loss. The identification of reliable biomarkers is crucial for early diagnosis and therapeutic intervention. This study explores an insight into current strategies and future approaches for improvement of the treatment, diagnosis, or prevention of AD. AD relevant data were collected from databases like PubMed, Google Scholar, and ScienceDirect. Our study findings reveal that traditional biomarkers such as amyloid-beta (Aβ) and tau proteins remain central to AD pathology, but emerging targets, including neurofilament light chain (NfL), triggering receptor expressed on myeloid cells 2 (TREM2), and synaptic proteins, are gaining attention for their diagnostic and prognostic value. Additionally, lipid peroxidation markers (4-HNE, MDA) and Cytokines (IL-6, TNF-α, and IL-1β) analyses have provided an invasive alternatives for disease monitoring. These advancements facilitate the development of precision medicine approaches, including targeted therapies aimed at modulating key pathological proteins.